May 26, 2016 8:23 PM ET

Biotechnology

Company Overview of BioRestorative Therapies, Inc.

Executive Profile

Gregory E. Lutz M.D.

Chief Medical Advisor for Spine Medicine, BioRestorative Therapies, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
----

Background

Dr. Gregory E. Lutz, M.D. has been the Chief Medical Advisor for Spine Medicine at BioRestorative Therapies, Inc. since March 3, 2014. Dr. Lutz is responsible for advancing the BioRestorative's brtxDISC(TM) Program including preparing the Company's Investigational New Drug/Investigational Device Exemption application with the U.S. Food and Drug Administration (FDA). In addition, He leads the efforts to design the trial protocol, identify trial sites and assist in the ...

Corporate Headquarters

40 Marcus Drive
Melville, New York 11747

United States

Phone: 631-760-8100
Fax: --

Board Members Memberships

Trustee
Co-founder, Chairman of The Board and Chief Marketing Officer

Education

MD
Georgetown University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$597.6K
Ian John Massey D.PhilChief Executive Officer, President and Director
StemCells Inc.
$386.2K
David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.Chief Executive Officer and Director
Caladrius Biosciences, Inc.
$541.4K
Steven A. Victor M.D.Chairman and Chief Executive Officer
IntelliCell BioSciences, Inc.
$275.0K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact BioRestorative Therapies, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.